Institutional investors purchased a net $28.1 thousand shares of GENE during the quarter ended June 2013. This may signal that the smart money is gaining interest in this company as the 0.46% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
KNIGHT CAPITAL AMERICAS LLC Bought 25.0 Thousand shares of Genetic Technologies Ltd